Eptigrilin 0.75mg/ml Infusion is a blood thinner which prevents formation of harmful blood clots. It is used in the treatment of a heart attack and also prevents the clotting of blood in the heart during an angioplasty (procedure to improve blood flow to the heart).

Eptigrilin 0.75mg/ml Infusion is used to prevent blood flow complications during an angioplasty and even in general

Uses of Eptigrilin Infusion

Prevention of Blood clots
Prevention of Heart attack

Benefits of Eptigrilin Infusion

In Prevention of Blood clots

Eptigrilin 0.75mg/ml Infusion prevents new blood clots from forming and prevents the existing ones from getting bigger. It works by blocking a substance in the body which is involved in blood clotting. Thus it helps your blood flow smoothly throughout the body. This can help reduce damage caused by clots in your lungs (pulmonary embolism), brain (stroke), heart (heart attack) or other blood vessels (thrombosis).

In Prevention of Heart attack

It prevents blood from clotting inside the veins and arteries. This helps the blood flow freely around your body thereby preventing a heart attack or stroke (or deep vein thrombosis or pulmonary embolism). Follow your doctor’s instructions carefully and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine.

show less

Side effects of Eptigrilin Infusion

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Eptigrilin

Bleeding
Decreased blood pressure

How to use Eptigrilin Infusion

Your doctor or nurse will give you this medicine. Kindly do not self-administer.

Safety advice

Alcohol

CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Eptigrilin 0.75mg/ml Infusion. Please consult your doctor.

Pregnancy

SAFE IF PRESCRIBED

Eptigrilin 0.75mg/ml Infusion is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast feeding

CAUTION

Eptigrilin 0.75mg/ml Infusion should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.

Driving

NOT RELEVANT

Not relevant, as Eptigrilin 0.75mg/ml Infusion is intended for use in hospitalised patients.

Kidney

CAUTION

Eptigrilin 0.75mg/ml Infusion should be used with caution in patients with kidney disease. Dose adjustment of Eptigrilin 0.75mg/ml Infusion may be needed. Please consult your doctor.
Use of Eptigrilin 0.75mg/ml Infusion is not recommended in patients with severe kidney disease.

Liver

CONSULT YOUR DOCTOR

There is limited information available on the use of Eptigrilin 0.75mg/ml Infusion in patients with liver disease. Please consult your doctor.
Use of Eptigrilin 0.75mg/ml Infusion is not recommended in patients with severe liver disease.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Eptigrilin 0.75mg/ml Infusion

₹88.44/ml of Infusion

Eptifab 0.75mg/ml Infusion

Abbott L

₹135.5/ml of infusion

53% costlier

Intiflo 0.75mg/ml Infusion

Cipla Ltd

₹87.44/ml of infusion

1% cheaper

Eptiflo 0.75mg/ml Infusion

Sun Pharmaceutical Industries Ltd

₹41.86/ml of infusion

53% cheaper

Interiglin 0.75mg/ml Infusion

Fulford India Ltd

₹108.61/ml of infusion

23% costlier

Integrilin Injection

Merck Ltd

₹102.96/ml of infusion

16% costlier

Quick tips

It is usually given by your nurse or doctor as an infusion (drip) into a vein.
It increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails or using sharp objects.
Notify your doctor if you see blood in your vomit, urine or stool (black, tarry stools or bright red blood).

Fact Box

Chemical Class

Amino acids, Peptides analogues

Habit Forming

Therapeutic Class

BLOOD RELATED

Action Class

Glycoprotein IIb/IIIa inhibitors

Patient concerns

My father in law is being admitted in hospital due to blood clot in brain. His right leg and arm seems to be paralysed. Doctors in the hospital not briefing us on the problem exactly. Need your second opinion. His age is 67. Having Smoking habit.

Dr. Sunil Sekhri

Diabetology

There are blood clots in the brain arteries

What are the health problems that one can get if the one keeps on taking a chronic stress and depression over a prolonged period of time. Seing that im experiencing some symtoms like chronic head ache, nausea, heart pain, gastrointiatinal bleeding, urine in the blood, sleep deprivation, weight loss due to exyreme thinking. Pls advise me in this connection

Dr. Pushkar Mani

Physician

Heart attack, Kidney problems all u can get

What are the trip t normal and high values What should be thresholds for ' no heart'' attack', minor attack and heart attack

Dr. Ila Jain Khandelwal

Pathology

Hello sir. Thank you for consulting with us. Trop T is read as either positive or increased or not positive. Positive Trop T level indicates heart attack and negative Trop t usually indicates no heart attack. Even in minor heart attack, Trop T is positive.

FAQs

Can the use of Eptigrilin 0.75mg/ml Infusion increase the risk of bleeding?

Yes, Eptigrilin 0.75mg/ml Infusion increases the risk of bleeding. Always be careful while doing activities that may cause an injury or bleeding. Tell your doctor immediately if you notice any abnormal bruising or bleeding.

What medicines should I avoid while taking Eptigrilin 0.75mg/ml Infusion?

Eptigrilin 0.75mg/ml Infusion can interact with several medicines. Do not take any medicine without talking to your doctor.

When will I feel better after taking Eptigrilin 0.75mg/ml Infusion?

Eptigrilin 0.75mg/ml Infusion reduces your risk of developing blood clots in the blood vessels of your leg, lungs, heart and brain. You may not feel any difference after taking Eptigrilin 0.75mg/ml Infusion. However, keep taking this medicine as prescribed by your doctor because you will still be getting its full benefits.

Top Cardiologists

Dr. Manjinder Sandhu

MBBS, MD, DNB, DM, Fellowship, Fellowship

4.7 ★

Dr. R. R. Kasliwal

MBBS, MD, DM, Fellowship

4.7 ★

Dr. Tapan Ghose

MBBS, DNB, MD, DNB, Fellowship, Fellowship

4.5 ★

Dr. Monik Mehta

MBBS, MD, DM, Fellowship

4.5 ★

Dr. Rajneesh Kapoor

MBBS, MD, DNB

5 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 871.
Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 355-56.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 485-46.
Eptifibatide. Ferentino, Italy: Patheon Italia S.p.A.; 1998 [revised Mar. 2013]. [Accessed 18 Mar. 2019] (online) Available from:
Drugs.com. Eptifibatide Pregnancy and Breastfeeding Warnings. [Accessed 18 Mar. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). Eptifibatide. [Accessed 18 Mar. 2019] (online) Available from:

Marketer details

Name: Zydus Cadila

Address: Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Country of origin: India

MRP

₹8843.76

Inclusive of all taxes

100.0 ml in 1 bottle

SOLD OUT

Notify me

We provide you with authentic, trustworthy and relevant information

Have issue with the content?